Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma

We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an...

Full description

Saved in:
Bibliographic Details
Main Authors: Twyla Bartel, Tracy Yarbrough, Lorraine De Blanche
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2016-07-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.172303
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324784662347776
author Twyla Bartel
Tracy Yarbrough
Lorraine De Blanche
author_facet Twyla Bartel
Tracy Yarbrough
Lorraine De Blanche
author_sort Twyla Bartel
collection DOAJ
description We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.
format Article
id doaj-art-37b5aa6a4dc9440eb13302a235deb76a
institution Kabale University
issn 1450-1147
1607-3312
language English
publishDate 2016-07-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series World Journal of Nuclear Medicine
spelling doaj-art-37b5aa6a4dc9440eb13302a235deb76a2025-08-20T03:48:36ZengThieme Medical and Scientific Publishers Pvt. Ltd.World Journal of Nuclear Medicine1450-11471607-33122016-07-01150320320510.4103/1450-1147.172303Use of marrow scintigraphy to confirm compensatory marrow rather than active myelomaTwyla Bartel0Tracy Yarbrough1Lorraine De Blanche2Global Advanced Imaging, PLLC, Little Rock, Arkansas, USAGlobal Advanced Imaging, PLLC, Little Rock, Arkansas, USACentral Arkansas Radiation Therapy Institute, Little Rock, Arkansas, USAWe present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.172303fluorodeoxyglucosemarrow scintigraphymultiple myelomaplasmacytoma
spellingShingle Twyla Bartel
Tracy Yarbrough
Lorraine De Blanche
Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
World Journal of Nuclear Medicine
fluorodeoxyglucose
marrow scintigraphy
multiple myeloma
plasmacytoma
title Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
title_full Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
title_fullStr Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
title_full_unstemmed Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
title_short Use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
title_sort use of marrow scintigraphy to confirm compensatory marrow rather than active myeloma
topic fluorodeoxyglucose
marrow scintigraphy
multiple myeloma
plasmacytoma
url http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.172303
work_keys_str_mv AT twylabartel useofmarrowscintigraphytoconfirmcompensatorymarrowratherthanactivemyeloma
AT tracyyarbrough useofmarrowscintigraphytoconfirmcompensatorymarrowratherthanactivemyeloma
AT lorrainedeblanche useofmarrowscintigraphytoconfirmcompensatorymarrowratherthanactivemyeloma